arrow
R

Raffaella Origa

irccs casa sollievo della sofferenza
H指数:31
被引数:5,961

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients

真实世界证据支持鲁斯帕特cept在临床复杂和重度铁过载患者中的安全性和有效性特征

2026-03-010
OAAI
Atrial fibrillation prevalence and its management in aging, transfusion-dependent patients with thalassemia: the FATHAL study

地中海贫血输血依赖性老年患者的心房颤动患病率及其管理:FATHAL研究

2026-01-290
OAAI
Pregnancy and childbirth in women with thalassemia: past and present

地中海贫血妇女的妊娠与分娩:过去与现状

2026-01-010
OA
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone
2025-12-010
PRE
Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study

甲状腺结节监测在依赖输血的地中海贫血中的比较超声研究

2025-10-150
OAAI
Pregnancy and Childbirth in Women with Thalassemia: Past and Present

地中海贫血妇女的妊娠与分娩:过去与现在

BLOOD
IF23.1
2024-11-050
PRE
Reply to Hepatocellular carcinoma in thalassemia and other hemoglobinopathies
CANCER
IF5.1
2023-03-140
OAAI
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021
CANCER
IF5.1
2022-11-0212
OAAI